Bridgefront Capital, LLC Kura Oncology, Inc. Transaction History

Bridgefront Capital, LLC

  • $236 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$10.71 - $18.33 $120,016 - $205,405
-11,206 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$11.78 - $16.98 $132,006 - $190,277
11,206 New
11,206 $180,000
Q1 2021

May 17, 2021
SELL
$24.75 - $39.14 $376,101 - $594,771
-15,196 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$29.0 - $41.62 $440,684 - $632,457
15,196 New
15,196 $496,000

Others Institutions Holding KURA

# of Institutions
181
Shares Held
80.2M
Call Options Held
148K
Put Options Held
63K
View Full List

About Kura Oncology, Inc.

KURA Quotes by TradingView
  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.31B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email